LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Key Hires Enterprise Therapeutics has recently onboarded key personnel including a Head of Regulatory Affairs and a Chief Medical Officer, indicating a focus on strengthening their leadership team to drive business growth and development.

Strategic Funding Rounds Successful funding rounds of $33.1M and $41M from investors like Panakes Partners and Novartis Venture Fund demonstrate investor confidence in Enterprise Therapeutics, providing potential opportunities for collaborations or partnerships.

Research & Development Focus With a dedication to novel therapies for respiratory diseases, Enterprise Therapeutics' focus on drug discovery and development presents opportunities for strategic partnerships with companies looking to expand their portfolio in this therapeutic area.

Industry Recognition Enterprise Therapeutics' financing achievements and notable hires have garnered attention within the pharmaceutical industry, opening doors for potential collaborations and business relationships based on their growing reputation.

Competitive Landscape Analysis By comparing Enterprise Therapeutics with similar companies like PhoreMost Ltd and Mission Therapeutics, sales professionals can identify competitive advantages and tailor their sales pitch to showcase Enterprise's unique value proposition.

Similar companies to Enterprise Therapeutics

Enterprise Therapeutics Tech Stack

Enterprise Therapeutics uses 8 technology products and services including Google Analytics, Font Awesome, Underscore.js, and more. Explore Enterprise Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Font Awesome
    Font Scripts
  • Underscore.js
    Javascript Libraries
  • RSS
    Miscellaneous
  • Windows Server
    Operating Systems
  • Bootstrap
    UI Frameworks
  • MediaElement.js
    Video Players
  • IIS
    Web Servers

Media & News

Enterprise Therapeutics's Email Address Formats

Enterprise Therapeutics uses at least 1 format(s):
Enterprise Therapeutics Email FormatsExamplePercentage
First@enterprisetherapeutics.comJohn@enterprisetherapeutics.com
41%
First.Last@enterprisetherapeutics.comJohn.Doe@enterprisetherapeutics.com
15%
FLast@enterprisetherapeutics.comJDoe@enterprisetherapeutics.com
3%
First@enterprisetherapeutics.comJohn@enterprisetherapeutics.com
41%

Frequently Asked Questions

Where is Enterprise Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Enterprise Therapeutics's main headquarters is located at University of Sussex Science Park Square Brighton, East Sussex BN1 9SB GB. The company has employees across 2 continents, including EuropeNorth America.

What is Enterprise Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Enterprise Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Enterprise Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Enterprise Therapeutics's official website is enterprisetherapeutics.com and has social profiles on LinkedIn.

How much revenue does Enterprise Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Enterprise Therapeutics's annual revenue reached $1.8M.

What is Enterprise Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Enterprise Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Enterprise Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Enterprise Therapeutics has approximately 13 employees across 2 continents, including EuropeNorth America. Key team members include Chief Scientific Officer, Co-Founder: M. G.Head Of Biology: H. D.Head Of Development: P. R.. Explore Enterprise Therapeutics's employee directory with LeadIQ.

What industry does Enterprise Therapeutics belong to?

Minus sign iconPlus sign icon
Enterprise Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Enterprise Therapeutics use?

Minus sign iconPlus sign icon
Enterprise Therapeutics's tech stack includes Google AnalyticsFont AwesomeUnderscore.jsRSSWindows ServerBootstrapMediaElement.jsIIS.

What is Enterprise Therapeutics's email format?

Minus sign iconPlus sign icon
Enterprise Therapeutics's email format typically follows the pattern of . Find more Enterprise Therapeutics email formats with LeadIQ.

How much funding has Enterprise Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Enterprise Therapeutics has raised $33M in funding. The last funding round occurred on Jan 29, 2024 for $33M.

When was Enterprise Therapeutics founded?

Minus sign iconPlus sign icon
Enterprise Therapeutics was founded in 2014.
Enterprise Therapeutics

Enterprise Therapeutics

Pharmaceutical ManufacturingEast Sussex, United Kingdom11-50 Employees

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.

In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. 

The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. The company benefits from a close working relationship with the School of Life Sciences at the University of Sussex.

Section iconCompany Overview

Headquarters
University of Sussex Science Park Square Brighton, East Sussex BN1 9SB GB
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $33M

    Enterprise Therapeutics has raised a total of $33M of funding over 7 rounds. Their latest funding round was raised on Jan 29, 2024 in the amount of $33M.

  • $10M

    Enterprise Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $33M

    Enterprise Therapeutics has raised a total of $33M of funding over 7 rounds. Their latest funding round was raised on Jan 29, 2024 in the amount of $33M.

  • $10M

    Enterprise Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.